New Research PaperCoronaryBiodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial
Coronary
Under a Creative Commons license
open access
Central Illustration
Key Words
acute myocardial infarction
biodegradable polymer
drug-eluting stent(s)
thin strut
Abbreviations and Acronyms
BCI
Bayesian credible interval
BP-SES
biodegradable-polymer sirolimus-eluting stent(s)
DP-EES
durable-polymer everolimus-eluting stent(s)
DES
drug-eluting stent(s)
PCI
percutaneous coronary intervention
PLLA
poly-l-lactic acid
RR
rate ratio
STEMI
ST-segment elevation myocardial infarction
Cited by (0)
Dr. John Bittl served as Guest Editor of this article.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
- ∗
Drs. Pilgrim and Muller contributed equally to this work.
© 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.